Alpha Tau Medical Ltd. (DRTSW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Los analistas estiman Beneficio por acción (EPS) de $-0.45 y ingresos de $0.00B para el próximo año fiscal.
Historial de Beneficio por acción (EPS): 2024: real $-0.45 vs est $-0.45 (superó +0%). 2025: real $-0.53 vs est $-0.51 (no alcanzó -3.8%). Precisión del analista: 98%.
